Business Context and Reporting Period
This Form 8-K reports on the 2019 Annual Meeting of Stockholders held by MacroGenics, Inc. on May 16, 2019. The filing details the voting results for three proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
A total of 37,047,070 shares were present or represented by proxy, representing approximately 75.91% of the 48,804,476 outstanding shares entitled to vote. All three proposals were approved:
- Proposal 1 (Director Election): Three Class III director nominees (Paulo Costa, Karen Ferrante, M.D., and Edward Hurwitz) were elected for three-year terms. Broker non-votes totaled 5,593,320 shares.
- Proposal 2 (Auditor Ratification): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2019.
- Proposal 3 (Executive Compensation): Stockholders approved, on an advisory basis, the compensation of named executive officers. Broker non-votes totaled 5,593,320 shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the specific terms and compensation details for the newly elected directors in the definitive proxy statement filed on April 5, 2019.
- Confirm the scope of the advisory vote on executive compensation and any subsequent changes to compensation plans.
- Note the significant number of broker non-votes (5,593,320) on Proposals 1 and 3, indicating shares held in street name where brokers lacked discretionary voting authority.